NEW YORK, April 25 -Qiagen has lent its RNAi expertise to scientists on the front lines of SARS research, stepping in to contribute its RNA interference design resource, along with its custom siRNA and other sample preparation and nucleic acid chemistry products to laboratories in Hong Kong, China, Singapore, and Canada, the company said this week.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.